Mercredi, 21 Novembre 2018
Dernières nouvelles
Principale » HealthEquity, Inc. (HQY) Position Boosted by UBS Asset Management Americas Inc

HealthEquity, Inc. (HQY) Position Boosted by UBS Asset Management Americas Inc

20 Juillet 2017

656021 shares were traded on HealthEquity, Inc.'s last session. Medici now owns $421,114,014 of stock as recorded in a recent Form 4 SEC filing. TIAA CREF Investment Management LLC raised its stake in shares of HealthEquity by 14.1% in the first quarter. The company's revenue for the quarter was up 25.9% compared to the same quarter a year ago. FMR LLC now owns 1,535,422 shares of the company's stock valued at $65,179,000 after buying an additional 286,981 shares during the last quarter. Arcadia Investment Management Corp MI raised its position in HealthEquity by 81.7% in the first quarter. BlackRock Inc. now owns 5,589,953 shares of the company's stock worth $237,293,000 after buying an additional 5,586,414 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of HealthEquity by 6.2% in the first quarter. Oppenheimer Asset Management Inc. bought a new position in shares of HealthEquity during the first quarter valued at about $106,000. Exane Derivatives bought a new position in shares of HealthEquity during the second quarter valued at about $132,000.

Hedge funds and other institutional investors have recently made changes to their positions in the company.

03/14/2017 - Wells Fargo began new coverage on HealthEquity, Inc. giving the company a "outperform" rating. (HQY) opened at 49.09 on Wednesday. The firm has a market cap of $3.05 billion, a price-to-earnings ratio of 95.60 and a beta of 1.78. HealthEquity has a 12 month low of $27.45 and a 12 month high of $54.95. The company has a 50-day moving average price of $48.61 and a 200 day moving average price of $45.03.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, June 6th. The company reported $0.19 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.16 by $0.03. The company had revenue of $55.40 million during the quarter, compared to analysts' expectations of $54.77 million. HealthEquity had a return on equity of 11.61% and a net margin of 17.04%. HealthEquity's revenue for the quarter was up 25.9% on a year-over-year basis. HealthEquity also reported earnings of $0.14 per share in the same quarter past year. Equities analysts anticipate that HealthEquity, Inc. will post $0.58 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: "HealthEquity, Inc. (NASDAQ:HQY)" was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and global copyright & trademark legislation. The correct version of this report can be read at https://www.chaffeybreeze.com/2017/07/19/healthequity-hqy-earns-media-impact-score-of-0-11-updated.html.

Man City ahead of Chelsea in the race to sign Madrid star
In London Morata will replace another Spanish striker Diego Costa , who is expected will return to Atletico Madrid. Neither club would have wanted Morata to pick up a training-ground injury that could jeopardise the move.

According to the latest research reports released, 2 analysts have issued a rating of "buy", 7 analysts "outperform", 1 analysts "hold", 0 analysts "underperform" and 0 analysts "sell". Chardan Capital reiterated a "buy" rating and issued a $53.00 price objective (up previously from $50.00) on shares of HealthEquity in a research note on Wednesday, March 22nd. On March 23 Barrington Research kept the stock rating at "Outperform" but raised the price target from $24.00 to $30.00. J P Morgan Chase & Co lifted their price objective on HealthEquity from $44.00 to $51.00 and gave the stock an "overweight" rating in a report on Wednesday, March 22nd. One analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. The company now has a consensus rating of "Buy" and a consensus price target of $50.22.

On Friday, June 23rd, Berkley Capital, Llc sold 54,967 shares of HealthEquity stock. The stock was sold at an average price of $43.44, for a total value of $434,400.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Darcy G. Mott sold 10,000 shares of the company's stock in a transaction on Thursday, April 20th.

Stock market analysts and brokers have recently amended their target prices on shares of HealthEquity, Inc. The disclosure for this sale can be found here. The stock was sold at an average price of $50.27, for a total transaction of $1,188,835.23. 750,565 shares of the company's stock were exchanged.

HealthEquity, Inc., launched on October 18, 2002, is a provider of a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators.